Background This study applies an umbrella review approach to summarise the global evidence on the risk of severe COVID-19 outcomes in patients with pre-existing health …
Y Lustig, E Sapir, G Regev-Yochay… - The Lancet …, 2021 - thelancet.com
Summary Background Concurrent with the Pfizer–BioNTech BNT162b2 COVID-19 vaccine roll-out in Israel initiated on Dec 19, 2020, we assessed the early antibody responses and …
M Wargny, L Potier, P Gourdy, M Pichelin, C Amadou… - Diabetologia, 2021 - Springer
Methods The CORONADO initiative is a French nationwide multicentre study of patients with diabetes hospitalised for COVID-19 with a 28-day follow-up. The patients were screened …
Y Du, N Zhou, W Zha, Y Lv - Nutrition, Metabolism and Cardiovascular …, 2021 - Elsevier
Aims As reported, hypertension may play an important role in adverse outcomes of coronavirus disease-2019 (COVID-19), but it still had many confounding factors. The aim of …
Y Du, Y Lv, W Zha, N Zhou, X Hong - Metabolism, 2021 - Elsevier
Background and purpose The coronavirus disease 2019 (COVID-19) pandemic presents an unprecedented health crisis to the entire world. As reported, the body mass index (BMI) may …
Tujuan penelitian ini adalah untuk menganalisis penyakit komorbid sebagai faktor risiko kematian akibat COVID-19 di RS Bhakti Dharma Husada Surabaya. Metode penelitian ini …
The prevalence of COVID-19-associated diabetes is not the result of a single event but of a combination of disease susceptibility associated with chronic illness and COVID-19-specific …
OK Fix, EA Blumberg, KM Chang, J Chu… - …, 2021 - Wiley Online Library
The aim of this document is to provide a concise scientific review of the currently available COVID‐19 vaccines and those in development, including mRNA, adenoviral vectors, and …
More than one and a half years have elapsed since the commencement of the coronavirus disease 2019 (COVID-19) pandemic, and the world is struggling to contain it. Being caused …